Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 1.00 |
| ▸ | SOAT1 | P35610 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.89 |
| ▸ | CNR1 | P21554 | 1/20 | 0.78 |
| ▸ | TERT | O14746 | 3/20 | 0.70 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.70 |
| ▸ | PPARG | P37231 | 3/20 | 0.70 |
| ▸ | PPARD | Q03181 | 3/20 | 0.70 |
| ▸ | PPARA | Q07869 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | BLM | P54132 | 2/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | FABP4 | P15090 | 2/20 | 0.70 |
| ▸ | GMNN | O75496 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oleamide SCHEMBL19814150 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL10445439 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL21983255 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL23528231 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL10445419 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL24340776 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL21501560 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL21654359 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL22419041 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| Oleamide SCHEMBL6668979 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2428566-B1 | GENE TRANSFER AGENT COMPOSITION CONTAINING POLYAMIDOAMINE DENDRON | PUBLIC UNIVERSITY CORP OSAKA PREFECTURE UNIVERSITY (JP) | 2015-08-26 | — | — | EP | disclosed |
| WO-2013172358-A1 | FUNCTIONAL COMPOUND, MOLECULAR ASSEMBLY CONTAINING FUNCTIONAL COMPOUND, COMPOSITION CONTAINING MOLECULAR ASSEMBLY, KIT, AND USE OF MOLECULAR ASSEMBLY, COMPOSITION OR KIT | 公立大学法人大阪府立大学 (JP) | 2013-11-21 | — | — | WO | disclosed |
| US-8557875-B2 | Gene transfer agent composition containing polyamidoamine dendron | PUBLIC UNIVERSITY CORPORATION OSAKA PREFECTURE UNIVERSITY (JP) | 2013-10-15 | — | — | US | disclosed |
| EP-2428566-A1 | GENE TRANSFER AGENT COMPOSITION CONTAINING POLYAMIDOAMINE DENDRON | Public University Corporation Osaka Prefecture University (JP) | 2012-03-14 | — | — | EP | disclosed |
| US-20120053233-A1 | GENE TRANSFER AGENT COMPOSITION CONTAINING POLYAMIDOAMINE DENDRON | PUBLIC UNIVERSITY CORPORATION OSAKA PREFECTURE UNIVERSITY (JP) | 2012-03-01 | — | — | US | disclosed |
| EP-0783296-B1 | NOVEL COMPOSITIONS FOR THE INTRODUCTION OF POLYANIONIC MATERIALS INTO CELLS | INEX PHARMACEUTICALS CORP (CA) | 2002-06-26 | — | — | EP | disclosed |
| EP-1179340-A2 | Compositions for the introduction of polyanionic materials into cells | INEX Pharmaceutical Corp. (CA) | 2002-02-13 | — | — | EP | disclosed |
| US-6268534-B1 | CONTACTING OLEYL BROMIDE WITH OLEYLAMINE UNDER CONDITIONS SUITABLE FOR THE FORMATION OF N,N-DIOLEYLAMINE; METHYLATION OF N,N-DIOLEYLAMINE UNDER CONDITIONS SUITABLE FOR FORMATION OF N,N-DIOLEYL-N,N-DIMETHYLAMMONIUM CHLORIDE | RIBOZYME PHARMACEUTICALS, INC. | 2001-07-31 | — | — | US | disclosed |
| US-5785992-A | LIPOSOMES AND CATIONIC COMPOUNDS | INEX PHARMACEUTICALS CORP. (CA) | 1998-07-28 | — | — | US | disclosed |
| EP-0783296-A1 | NOVEL COMPOSITIONS FOR THE INTRODUCTION OF POLYANIONIC MATERIALS INTO CELLS | INEX Pharmaceutical Corp. (CA) | 1997-07-16 | — | — | EP | disclosed |
| WO-1996010390-A1 | NOVEL COMPOSITIONS FOR THE INTRODUCTION OF POLYANIONIC MATERIALS INTO CELLS | INEX PHARMACEUTICALS CORP. (CA) | 1996-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053233-A1 | GENE TRANSFER AGENT COMPOSITION CONTAINING POLYAMIDOAMINE DENDRON | CXCR4, KPNA2, MCTS1 | FAAH 2620/4885SOAT1 2601/4885CYP1A2 1876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.